Coronary CatheterizationNCT01753817
Assessment of Radial Artery Patency Following Catheterization With a 7F Sheath
An observational study of Coronary Catheterization and Transradial Patency, run by Jaffe, Ronen, M.D. at 1 site in Israel.
Trial summary
Radial artery occlusion may occur after performance of coronary catheterization via the radial artery (transradial approach). In some cases it may be desirable to insert large (7F) catheters via the radial artery, however the impact of increased catheter size on subsequent radial artery patency is unclear. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Coronary Catheterization, Transradial Patency
- How many people
- 200 participants
- Where
- 1 siteIsrael
- Study dates
- Jan 2013to Jan 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Two-hundred subjects who have previously undergone transradial cathetrization between the years 1999 and 2012 with a 7F sheath will be identified in the Lady Davis Carmel Medical Center Catheterization laboratory computerized database.
Who may be able to join
- Previous transradial catheterization with a 7F vascular sheath
Who cannot join
- Inability to give informed consent
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Observational Study of Radial Artery Patency Following Catheterization With a 7F Sheath
Radial artery occlusion may occur after performance of coronary catheterization via the radial artery (transradial approach). In some cases it may be desirable to insert large (7F) catheters via the radial artery, however the impact of increased catheter size on subsequent radial artery patency is unclear. We hypothesize that radial artery occlusion following 7F catheterization is rare and occurs in < 5% of the cases.
Read the detailed description
Background:
Coronary catheterization is a commonly performed diagnostic and therapeutic procedure. The procedure is most commonly performed via the transfemoral approach (via the femoral artery). Recently the transradial approach (via the radial artery) has been gaining popularity since it is associated with decreased risk of bleeding and facilitates patient mobilization following the procedure (1-3). During the catheterization procedure a sheath (tube) is inserted into the access artery so as to enable insertion of catheters and devices into the body. Vascular sheaths may have different internal diameters, which are measured in French (F) units. Commonly used sheath sizes for coronary catheterization are 5F and 6F, however use of larger 7F sheaths is beneficial when more complex procedures are performed such as insertion of two coronary stents. Use of a 7F sheath creates a slightly larger orifice within the blood vessel wall and may potentially increase the risk of damage to the vessel wall and hemorrhage.
The palm of the hand normally receives dual blood supply via the radial and ulnar arteries. Prior to performing transradial catheterization the ability of the ulnar artery to supply blood to the whole palm is confirmed by performing an Allen Test, in order to avoid palmar ischemia if the radial artery becomes occluded following the procedure. Radial artery occlusion in the presence of a normal pre-procedural Allen Test is almost universally asymptomatic, however it may preclude future use of the radial artery for vascular access or as a coronary graft if bypass surgery is performed. The frequency of radial artery occlusion following transradial catheterization ranges from 5% to 15% in different reports (4), depending on many factors such patient selection, degree of anticoagulation during the procedure and the time interval between performance of the procedure and studying the radial artery patency. Use of larger sheaths has also been reported as a risk factor for radial artery occlusion (5), however the true incidence of this complication is unclear. It is desirable to discover the true rate of radial artery occlusion following catheterization with a 7F sheath, since such knowledge may assist physicians in planning the optimal catheterization strategy.
Aims:
The aim of the study will be to examine the occurrence of radial artery occlusion following transradial catheterization with a 7F sheath.
Hypothesis:
Radial artery occlusion following 7F catheterization is rare and occurs in < 5% of the cases.
Methods:
The study will be performed as part of Mr. Dan Levin's required Medical School Thesis research at the Faculty of Medicine, Technion IIT, Haifa, Israel. Two-hundred subjects who have previously undergone transradial catheterization between the years 1999 and 2012 with a 7F sheath will be identified in the Lady Davis Carmel Medical Center Catheterization laboratory computerized database. The subjects will be contacted by the study investigators and will be invited to a meeting with the investigators at Carmel Medical Center. The study protocol consists of a single meeting between the investigators and the study subjects. During this meeting the subjects will be given explanation of the study protocol. If they consent to participate in the study they will sign an informed consent form, undergo physical examination of the reverse Allen test and ultrasound examination of the patency of the radial artery. Radial artery patency will be studied with the reverse Allen test. This test is performed by simultaneously occluding both the radial and ulnar arteries until no pulse signal is detected with a pulse oximeter placed on the index finger. The pressure on the radial artery is then released and reappearance of the pulse signal on the oximeter is documented-signifying antegrade flow in the radial artery. This test is not associated with any reported complications or morbidity. Radial artery flow will be studied with Doppler ultrasound. The ultrasound test will be performed by Dr Salim Adawi at no cost. The ultrasound test is a routine non-invasive study which is not associated with any reported complications or morbidity. Clinical and procedural data will be collected in the CRF form in order to characterize risk factors for radial artery occlusion.
Endpoints:
- Normal reverse Allen test.
- Antegrade flow in the radial artery by ultrasound.
Number of participants:
The Lady Davis Carmel Medical Center catheterization laboratory database will be scanned in order to identify all patients who have undergone transradial catheterization with a 7F sheath. Two-hundred patients, both men and women, will be recruited to the study.
Inclusion and exclusion criteria:
Two-hundred Hebrew-speaking subjects (male and female) who have previously undergone 7F transradial cardiac catheterization at the Lady Davis Carmel Medical Center between 1999 and 2012 will be contacted. Upon giving informed consent they will be recruited to the study.
Statistical analysis Univariate and multivariate analysis will be performed in order to identify demographic, clinical and procedural characteristics that are associated with radial artery occlusion.
References
- Amoroso et al. Transradial access for primary percutaneous coronary intervention: the next standard of care? Heart 2010;96:1341-1344.
- Freestone et al. Transradial cardiac procedures: The state of the art. Heart 2010;96:883-891.
- Bertrand et al. Transradial Approach for Coronary Angiography and Interventions: Results of the First International Transradial Practice Survey. JACC Intv. 2010;3;1022-1031.
- Pancholy et al. Effect of Duration of Hemostatic Compression on Radial Artery Occlusion After Transradial Access. CCI 2012;79:78-81.
- Uhlemann et al. The Leipzig Prospective Vascular Ultrasound Registry in Radial Artery Catheterization. JACC Intv 2012;5:36-43.
- Conditions
- Coronary Catheterization, Transradial Patency
- Keywords
- Coronary catheterization, Transradial patency
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Study cohort | Cohort of patients who have previously undergone transradial catheterization with the use of a 7F vascular sheath |
What is being measured
The primary outcome is the main question the study is designed to answer.
Normal reverse Allen test
Radial artery patency will be studied with the reverse Allen test. This test is performed by simultaneously occluding both the radial and ulnar arteries until no pulse signal is detected with a pulse oximeter placed on the index finger. The pressure on the radial artery is then released and reappearance of the pulse signal on the oximeter is documented-signifying antegrade flow in the radial artery. This test is not associated with any reported complications or morbidity.
Measured: Within 2 years of the initial procedure
Secondary outcomes (1)
Antegrade flow in the radial artery by ultrasound
Radial artery flow will be studied with Doppler ultrasound
Measured: Within 2 years of the initial procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Dec 2012 (estimated)
- Study startJan 2013
- Primary completionJul 2014 (estimated)
- Study completionJan 2015 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Coronary CatheterizationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Jaffe, Ronen, M.D.
- Responsible party
- Sponsor
- Investigators
- Ronen Jaffe, MD, Principal investigator, Carmel Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01753817
- Sponsor's protocol ID
- CMC-12-0016 CTIL
- Status last verified
- Dec 2012
- First submitted
- 18 Dec 2012
- Last updated
- 27 Dec 2012
- Results posted
- No
- Data monitoring committee
- No
Publications
Amoroso G, Kiemeneij F. Transradial access for primary percutaneous coronary intervention: the next standard of care? Heart. 2010 Sep;96(17):1341-4. doi: 10.1136/hrt.2010.196824.
PubMed 20801852Freestone B, Nolan J. Transradial cardiac procedures: the state of the art. Heart. 2010 Jun;96(11):883-91. doi: 10.1136/hrt.2007.134213. No abstract available.
PubMed 20478867Bertrand OF, Rao SV, Pancholy S, Jolly SS, Rodes-Cabau J, Larose E, Costerousse O, Hamon M, Mann T. Transradial approach for coronary angiography and interventions: results of the first international transradial practice survey. JACC Cardiovasc Interv. 2010 Oct;3(10):1022-31. doi: 10.1016/j.jcin.2010.07.013.
PubMed 20965460Pancholy SB, Patel TM. Effect of duration of hemostatic compression on radial artery occlusion after transradial access. Catheter Cardiovasc Interv. 2012 Jan 1;79(1):78-81. doi: 10.1002/ccd.22963. Epub 2011 May 16.
PubMed 21584923Uhlemann M, Mobius-Winkler S, Mende M, Eitel I, Fuernau G, Sandri M, Adams V, Thiele H, Linke A, Schuler G, Gielen S. The Leipzig prospective vascular ultrasound registry in radial artery catheterization: impact of sheath size on vascular complications. JACC Cardiovasc Interv. 2012 Jan;5(1):36-43. doi: 10.1016/j.jcin.2011.08.011.
PubMed 22230148
Study at a glance
From the registry record, last updated by the sponsor on 27 Dec 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Observational Study of Radial Artery Patency Following Catheterization With a 7F Sheath
- ClinicalTrials.gov ID
- NCT01753817
- Acronym / sponsor ID
- CMC-12-0016 CTIL
- Conditions
- Coronary Catheterization, Transradial Patency
- Keywords
- Coronary catheterization, Transradial patency
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Jaffe, Ronen, M.D.
- Study start
- Jan 2013
- Primary completion
- Jul 2014 (estimated)
- Study completion
- Jan 2015 (estimated)
- First posted
- 20 Dec 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Radial artery occlusion may occur after performance of coronary catheterization via the radial artery (transradial approach). In some cases it may be desirable to insert large (7F) catheters via the radial artery, however the impact of increased catheter size on subsequent radial artery patency is unclear. We hypothesize that radial artery occlusion following 7F catheterization is rare and occurs in < 5% of the cases.
Detailed description
Background:
Coronary catheterization is a commonly performed diagnostic and therapeutic procedure. The procedure is most commonly performed via the transfemoral approach (via the femoral artery). Recently the transradial approach (via the radial artery) has been gaining popularity since it is associated with decreased risk of bleeding and facilitates patient mobilization following the procedure (1-3). During the catheterization procedure a sheath (tube) is inserted into the access artery so as to enable insertion of catheters and devices into the body. Vascular sheaths may have different internal diameters, which are measured in French (F) units. Commonly used sheath sizes for coronary catheterization are 5F and 6F, however use of larger 7F sheaths is beneficial when more complex procedures are performed such as insertion of two coronary stents. Use of a 7F sheath creates a slightly larger orifice within the blood vessel wall and may potentially increase the risk of damage to the vessel wall and hemorrhage.
The palm of the hand normally receives dual blood supply via the radial and ulnar arteries. Prior to performing transradial catheterization the ability of the ulnar artery to supply blood to the whole palm is confirmed by performing an Allen Test, in order to avoid palmar ischemia if the radial artery becomes occluded following the procedure. Radial artery occlusion in the presence of a normal pre-procedural Allen Test is almost universally asymptomatic, however it may preclude future use of the radial artery for vascular access or as a coronary graft if bypass surgery is performed. The frequency of radial artery occlusion following transradial catheterization ranges from 5% to 15% in different reports (4), depending on many factors such patient selection, degree of anticoagulation during the procedure and the time interval between performance of the procedure and studying the radial artery patency. Use of larger sheaths has also been reported as a risk factor for radial artery occlusion (5), however the true incidence of this complication is unclear. It is desirable to discover the true rate of radial artery occlusion following catheterization with a 7F sheath, since such knowledge may assist physicians in planning the optimal catheterization strategy.
Aims:
The aim of the study will be to examine the occurrence of radial artery occlusion following transradial catheterization with a 7F sheath.
Hypothesis:
Radial artery occlusion following 7F catheterization is rare and occurs in < 5% of the cases.
Methods:
The study will be performed as part of Mr. Dan Levin's required Medical School Thesis research at the Faculty of Medicine, Technion IIT, Haifa, Israel. Two-hundred subjects who have previously undergone transradial catheterization between the years 1999 and 2012 with a 7F sheath will be identified in the Lady Davis Carmel Medical Center Catheterization laboratory computerized database. The subjects will be contacted by the study investigators and will be invited to a meeting with the investigators at Carmel Medical Center. The study protocol consists of a single meeting between the investigators and the study subjects. During this meeting the subjects will be given explanation of the study protocol. If they consent to participate in the study they will sign an informed consent form, undergo physical examination of the reverse Allen test and ultrasound examination of the patency of the radial artery. Radial artery patency will be studied with the reverse Allen test. This test is performed by simultaneously occluding both the radial and ulnar arteries until no pulse signal is detected with a pulse oximeter placed on the index finger. The pressure on the radial artery is then released and reappearance of the pulse signal on the oximeter is documented-signifying antegrade flow in the radial artery. This test is not associated with any reported complications or morbidity. Radial artery flow will be studied with Doppler ultrasound. The ultrasound test will be performed by Dr Salim Adawi at no cost. The ultrasound test is a routine non-invasive study which is not associated with any reported complications or morbidity. Clinical and procedural data will be collected in the CRF form in order to characterize risk factors for radial artery occlusion.
Endpoints:
- Normal reverse Allen test.
- Antegrade flow in the radial artery by ultrasound.
Number of participants:
The Lady Davis Carmel Medical Center catheterization laboratory database will be scanned in order to identify all patients who have undergone transradial catheterization with a 7F sheath. Two-hundred patients, both men and women, will be recruited to the study.
Inclusion and exclusion criteria:
Two-hundred Hebrew-speaking subjects (male and female) who have previously undergone 7F transradial cardiac catheterization at the Lady Davis Carmel Medical Center between 1999 and 2012 will be contacted. Upon giving informed consent they will be recruited to the study.
Statistical analysis Univariate and multivariate analysis will be performed in order to identify demographic, clinical and procedural characteristics that are associated with radial artery occlusion.
References
- Amoroso et al. Transradial access for primary percutaneous coronary intervention: the next standard of care? Heart 2010;96:1341-1344.
- Freestone et al. Transradial cardiac procedures: The state of the art. Heart 2010;96:883-891.
- Bertrand et al. Transradial Approach for Coronary Angiography and Interventions: Results of the First International Transradial Practice Survey. JACC Intv. 2010;3;1022-1031.
- Pancholy et al. Effect of Duration of Hemostatic Compression on Radial Artery Occlusion After Transradial Access. CCI 2012;79:78-81.
- Uhlemann et al. The Leipzig Prospective Vascular Ultrasound Registry in Radial Artery Catheterization. JACC Intv 2012;5:36-43.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Study cohort | – | –Cohort of patients who have previously undergone transradial catheterization with the use of a 7F vascular sheath |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Two-hundred subjects who have previously undergone transradial cathetrization between the years 1999 and 2012 with a 7F sheath will be identified in the Lady Davis Carmel Medical Center Catheterization laboratory computerized database.
Key inclusion criteria (1 listed)
- Previous transradial catheterization with a 7F vascular sheath
Key exclusion criteria (1 listed)
- Inability to give informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Normal reverse Allen test
Time frame: Within 2 years of the initial procedure
Radial artery patency will be studied with the reverse Allen test. This test is performed by simultaneously occluding both the radial and ulnar arteries until no pulse signal is detected with a pulse oximeter placed on the index finger. The pressure on the radial artery is then released and reappearance of the pulse signal on the oximeter is documented-signifying antegrade flow in the radial artery. This test is not associated with any reported complications or morbidity.
1 secondary outcome
Antegrade flow in the radial artery by ultrasound
Time frame: Within 2 years of the initial procedure
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Dec 2012.
- Background: PubMed 20801852Amoroso G, Kiemeneij F. Transradial access for primary percutaneous coronary intervention: the next standard of care? Heart. 2010 Sep;96(17):1341-4. doi: 10.1136/hrt.2010.196824.
- Background: PubMed 20478867Freestone B, Nolan J. Transradial cardiac procedures: the state of the art. Heart. 2010 Jun;96(11):883-91. doi: 10.1136/hrt.2007.134213. No abstract available.
- Background: PubMed 20965460Bertrand OF, Rao SV, Pancholy S, Jolly SS, Rodes-Cabau J, Larose E, Costerousse O, Hamon M, Mann T. Transradial approach for coronary angiography and interventions: results of the first international transradial practice survey. JACC Cardiovasc Interv. 2010 Oct;3(10):1022-31. doi: 10.1016/j.jcin.2010.07.013.
- Background: PubMed 21584923Pancholy SB, Patel TM. Effect of duration of hemostatic compression on radial artery occlusion after transradial access. Catheter Cardiovasc Interv. 2012 Jan 1;79(1):78-81. doi: 10.1002/ccd.22963. Epub 2011 May 16.
- Background: PubMed 22230148Uhlemann M, Mobius-Winkler S, Mende M, Eitel I, Fuernau G, Sandri M, Adams V, Thiele H, Linke A, Schuler G, Gielen S. The Leipzig prospective vascular ultrasound registry in radial artery catheterization: impact of sheath size on vascular complications. JACC Cardiovasc Interv. 2012 Jan;5(1):36-43. doi: 10.1016/j.jcin.2011.08.011.
Related trials for Coronary Catheterization
Not yet recruiting
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction
Not yet recruiting
Novel Wearable Device for Heart Failure Management
Heart Failure
RecruitingPhase 4
Propofol-Ketamine Versus Sevoflurane for Laryngeal Mask Anesthesia in Pediatric Cardiac Catheterization
Propofol, Ketamine
RecruitingObservational study
Comparison of Cardiac Index Measurement Using Right Ventricular Pressure Curve Analysis and Thermodilution Via a Swan-Ganz IQ™ Catheter.
Septic Shock
RecruitingObservational study
Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension
Pulmonary Hypertension, Pulmonary Arterial Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ronen Jaffe, MD principal investigator
Carmel Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Coronary Catheterization and Transradial Patency, run by Jaffe, Ronen, M.D. at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 27 Dec 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ronen Jaffe, MD (972-50-6265830, jaffe@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Normal reverse Allen test (time frame: Within 2 years of the initial procedure). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01753817, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2012.